Browsing Tag
Australia
505 posts
Clover Biopharmaceuticals stock in focus as new RSV re-vaccination data targets a gap GSK has not solved
Clover Biopharmaceuticals says new RSV re-vaccination data beat Arexvy in older adults. Read what this could mean for the adult vaccine market.
TZ Limited (ASX: TZL) loses CEO eight days after appointment as investor confidence tests debt-heavy balance sheet
TZ Limited (ASX: TZL) CEO resigns 8 days after appointment as debt deadline looms and shares fall 23%. Read our analysis of what this means for investors.
‘Not our war’: Germany, Japan, Italy flatly reject Trump’s Hormuz warship demand
Germany, Japan, Italy and Australia reject Trump's demand for warships at the Strait of Hormuz as the US-Israel war on Iran enters its third week.
How Caterpillar Inc.’s RPMGlobal deal deepens its software grip on the mining value chain
Caterpillar Inc. acquires RPMGlobal to expand digital mining integration and recurring revenue. Discover what this means for strategy and investors.
Fever-Tree Drinks (LON: FEVR) posts stronger-than-expected FY25 results as Molson Coors transition pays off
Fever-Tree exceeds FY25 expectations and launches new £30M buyback. Find out how its US strategy and soft drink push could drive growth in 2026.
Energy Fuels (NYSE: UUUU) to buy Australian Strategic Materials (ASX: ASM) to form ex-China rare earth mine-to-alloy platform
Energy Fuels is acquiring ASM to create the largest rare earths mine-to-alloy platform outside China. Find out what this means for the global supply chain.
Robert Walters (LON: RWA) Q4 2025 results: UK hiring rebounds, but Europe and Asia lag amid restructuring push
Robert Walters grew UK hiring by 25% in Q4 2025, but Europe remains challenged. Find out what this means for its 2026 strategy and global recruitment trends.
Little Green Pharma (ASX: LGP) to acquire Cannatrek in all-share deal creating vertically integrated cannabis leader
Discover how Little Green Pharma’s merger with Cannatrek is set to reshape Australia’s cannabis sector and accelerate GMP-certified expansion into Europe.
Island Pharmaceuticals (ASX: ILA) awaits FDA clearance for Galidesivir as Animal Rule review enters final phase
Island Pharmaceuticals confirms no FDA setbacks on Galidesivir. Find out what this means for its Marburg virus study and broader regulatory strategy.
Co-Diagnostics (NASDAQ: CODX) secures Australian patent for Co-Dx PCR platform technologies
Co-Diagnostics lands its first patent for the Co-Dx PCR platform in Australia. Find out what it means for global expansion and diagnostic disruption.